Evidence map›Paper›PMID 29230440›Full record

ArticleChemical communications (Cambridge, England)2017

N-Gemini peptides: cytosolic protease resistance via N-terminal dimerization of unstructured peptides.

Effrat L Fayer, William M Gilliland, J Michael Ramsey, Nancy L Allbritton, Marcey L Waters

Open access · greenAbstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Effrat L FayerDepartment of Chemistry, CB 3290, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. mlwaters@email.unc.edu.
William M Gilliland
J Michael Ramsey
Nancy L Allbritton
Marcey L Waters
University of North Carolina at Chapel Hill · US

Funding

Protectides: A tool for drug target assays in myelomaR01EB011763 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ALLBRITTON, NANCY L. · 2010 to 2013
$2.2M
NIBIB NIH HHS R01 EB011763
6 · The paper itself

Abstract

Herein we describe a synthetically simple strategy for increasing the lifetime of unstructured peptides in cytosolic environment via dimerization at the N-terminus to block threading into the catalytic cleft of cytosolic proteases. We establish this approach with kinase substrates, allowing for phosphorylation in cells as a demonstration of protease resistance.

Indexed as

Cell LineCytosolDimerizationHeLa CellsHumansMolecular StructurePeptide HydrolasesPeptidesProtease InhibitorsPeptide HydrolasesPeptidesProtease Inhibitors

Identifiers

PMID29230440
PMCPMC6034174
OpenAlexW2775578041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.